IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 22, 2024 at 04:07 pm EST
Share
iRhythm Technologies, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 132.51 million compared to USD 112.62 million a year ago. Net loss was USD 38.7 million compared to USD 20.2 million a year ago. Basic loss per share from continuing operations was USD 1.26 compared to USD 0.67 a year ago. Diluted loss per share from continuing operations was USD 1.26 compared to USD 0.67 a year ago.
For the full year, sales was USD 492.68 million compared to USD 410.92 million a year ago. Net loss was USD 123.41 million compared to USD 116.16 million a year ago. Basic loss per share from continuing operations was USD 4.04 compared to USD 3.88 a year ago.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
IRHYTHM TECHNOLOGIES, INC. 
